Sign InBreakout Stocks of Week 26 @ TASE
NASDAQ was up last week (week 25) by 2.43% ending at 26,517.93 points after gaining 629.09 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Kardan Real Estate Enterprise And Development Ltd TASE:KARE. This stock has had a buy signal since Jun 18, 2026 when the price was ₪578.20 , but have so far fallen -1.37% to ₪570.30. Some other companies are on our watchlist to, among these are Teva Pharmaceutical Industries Limited TASE:TEVA Cellcom Israel Ltd. TASE:CEL Israel Canada (t.r) Ltd TASE:ISCN and Sofwave Medical Ltd. TASE:SOFW which all got a breakout pattern emerging.
| Date | Company | Price | Change |
|---|---|---|---|
| Kardan Real Estate Enterprise And Development Ltd | ₪570.30 | ₪585.80 ( 24th Jun 2026 ) | 2.72% |
| Teva Pharmaceutical Industries Limited | ₪9,432.00 | ₪10,000.00 ( 24th Jun 2026 ) | 6.02% |
| Cellcom Israel Ltd. | ₪3,230.00 | ₪3,111.00 ( 24th Jun 2026 ) | -3.68% |
| Israel Canada (t.r) Ltd | ₪1,819.00 | ₪1,758.00 ( 24th Jun 2026 ) | -3.35% |
| Sofwave Medical Ltd. | ₪4,128.00 | ₪4,124.00 ( 24th Jun 2026 ) | -0.0969% |
Kardan Real Estate Enterprise And Development Ltd
TASE:KAREThe Kardan Real Estate Enterprise And stock price fell by -1.37% on the last day (Friday, 19th Jun 2026) from ₪578.20 to ₪570.30. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 3.08% from a day low at ₪565.10 to a day high of ₪582.50. The price has fallen in 8 of the last 10 days and is down by -5% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -3 thousand shares and in total, 7 thousand shares were bought and sold for approximately ₪4.15 million.
Kardan Real Estate Enterprise And holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
The Teva Pharmaceutical Industries Limited stock price gained 1.80% on the last trading day (Friday, 19th Jun 2026), rising from ₪9,265.00 to ₪9,432.00. During the last trading day the stock fluctuated 3.19% from a day low at ₪9,221.00 to a day high of ₪9,515.00. The price has fallen in 6 of the last 10 days and is down by -5.35% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 766 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately ₪17.99 billion.
Teva Pharmaceutical Industries Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About Teva Pharmaceutical Industries Limited:
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
The Cellcom Israel Ltd. stock price gained 1.10% on the last trading day (Friday, 19th Jun 2026), rising from ₪3,195.00 to ₪3,230.00. During the last trading day the stock fluctuated 3.31% from a day low at ₪3,145.00 to a day high of ₪3,249.00. The price has fallen in 6 of the last 10 days and is down by -11.58% for this period. Volume fell on the last day by -306 thousand shares and in total, 259 thousand shares were bought and sold for approximately ₪837.23 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Cellcom Israel Ltd. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About Cellcom Israel Ltd.:
Cellcom Israel Ltd. provides cellular communications services in Israel. It operates in two segments, Real Estate and Net. The company offers internet access and infrastructure, internet television, international telephony, landline telephony, and transmission services for business customers and telecommunications operators. It also provides switchboard, communication systems management, and information security services; and conference call, server hosting, and cloud services, as well as equipment and repair services for end equipment. As of December 31, 2021, it had approximately 10.7 million cellular subscribers. Cellcom Israel Ltd. was incorporated in 1994 and is headquartered in Netanya, Israel. Cellcom Israel Ltd. operates as a subsidiary of Discount Investment Corporation Ltd.
The Israel Canada (t.r) Ltd stock price gained 0.83% on the last trading day (Friday, 19th Jun 2026), rising from ₪1,804.00 to ₪1,819.00. During the last trading day the stock fluctuated 3.51% from a day low at ₪1,768.00 to a day high of ₪1,830.00. The price has fallen in 5 of the last 10 days and is down by -6.29% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 651 thousand more shares were traded than the day before. In total, 760 thousand shares were bought and sold for approximately ₪1.38 billion.
Israel Canada (t.r) Ltd holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
The Sofwave Medical Ltd. stock price gained 0.707% on the last trading day (Friday, 19th Jun 2026), rising from ₪4,099.00 to ₪4,128.00. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 3.64% from a day low at ₪4,033.00 to a day high of ₪4,180.00. The price has risen in 6 of the last 10 days but is still down by -2.34% for this period. Volume fell on the last day by -94 thousand shares and in total, 54 thousand shares were bought and sold for approximately ₪222.66 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Sofwave Medical Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
GOLDEN STAR
| Ticker | Change | Signal Date |
|---|---|---|
NESR
$25.06
|
0.439% | Jun 22 |
IDYA
$28.98
|
25.19% | Jun 12 |
PHM
$118.49
|
14.53% | Jun 10 |
DHI
$146.71
|
13.50% | Jun 10 |
EAT
$140.46
|
20.94% | Jun 05 |
